Comment on: Effectiveness and safety of an institutional aminoglycoside-based regimen as empirical treatment of patients with pyelonephritis-Reference-Cited by-同舟云学术

Comment on: Effectiveness and safety of an institutional aminoglycoside-based regimen as empirical treatment of patients with pyelonephritis

Published:2020-09-02 Issue:12 Volume:75 Page:3696-3697
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Spriet Isabel¹,van Hest Reinier M²,Peetermans Willy E³,Debaveye Yves⁴

Affiliation:

1. Pharmacy Department, University Hospitals Leuven, Leuven and Department of Pharmaceutical and Pharmacological Sciences, KU Leuven – University of Leuven, Belgium, Belgium

2. Department of Hospital Pharmacy & Clinical Pharmacology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands

3. Department of Internal Medicine, University Hospitals Leuven, Belgium and Department of Immunology and Microbiology, KU Leuven – University of Leuven, Belgium

4. Department of Intensive Care Medicine, University Hospitals Leuven, Belgium and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, University of Leuven, Belgium

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/75/12/3696/34291405/dkaa348.pdf

Reference7 articles.

1. Effectiveness and safety of an institutional aminoglycoside-based regimen as empirical treatment of patients with pyelonephritis;Elbaz;J Antimicrob Chemother,2020

2. Higher versus standard amikacin single dose in emergency department patients with severe sepsis and septic shock: a randomised controlled trial;De Winter;Int J Antimicrob Agents,2018

3. Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity;Galvez;Int J Antimicrob Agents,2011

4. Population pharmacokinetics of amikacin administered once daily in patients with different renal functions;Arechiga-Alvarado;Antimicrob Agents Chemother,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantification and Explanation of the Variability of First-Dose Amikacin Concentrations in Critically Ill Patients Admitted to the Emergency Department: A Population Pharmacokinetic Analysis;European Journal of Drug Metabolism and Pharmacokinetics;2021-07-23

2. Effectiveness and safety of an institutional aminoglycoside-based regimen as empirical treatment of patients with pyelonephritis—authors’ response;Journal of Antimicrobial Chemotherapy;2020-09-15